Mersana Therapeutics Liabilities 2024

Mersana Therapeutics Aktienanalyse

What does Mersana Therapeutics do?

Mersana Therapeutics Inc is a biotechnology company based in Cambridge, Massachusetts, USA. Founded in 2001, the company focuses on developing novel targeted cancer therapies based on the innovative Targeted Payload Apex platform. The company's pipeline includes multiple product candidates in various stages of clinical development, including XMT-1536 and XMT-1592. Mersana Therapeutics Inc collaborates with leading oncologists, scientists, and research institutes to advance its technologies and develop high-quality, safe, and effective therapies for cancer patients. The company's business model is based on utilizing its technology platform and product discovery capabilities to develop novel drugs. It is divided into different business areas targeting different medical applications, including oncology, ophthalmology, immunology, and metabolic diseases. Mersana Therapeutics Inc aims to improve the efficacy, safety, and tolerance of cancer therapies and meet the unmet medical need for targeted cancer treatments. Mersana Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Mersana Therapeutics's Liabilities

Mersana Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Mersana Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Mersana Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Mersana Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Mersana Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Mersana Therapeutics Stock

What is the level of liabilities of Mersana Therapeutics this year?

Mersana Therapeutics has a debt balance of 189.16 M USD this year.

What were the liabilities of Mersana Therapeutics compared to the previous year?

The liabilities of Mersana Therapeutics have increased by -21.93% dropped compared to the previous year.

What are the consequences of high debt for investors of Mersana Therapeutics?

High liabilities can pose a risk for investors of Mersana Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Mersana Therapeutics?

Low liabilities mean that Mersana Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Mersana Therapeutics affect the company?

An increase in liabilities of Mersana Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Mersana Therapeutics affect the company?

A decrease in the liabilities of Mersana Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Mersana Therapeutics?

Some factors that can influence the liabilities of Mersana Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Mersana Therapeutics so important for investors?

The liabilities of Mersana Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Mersana Therapeutics take to modify the liabilities?

To change its liabilities, Mersana Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Mersana Therapeutics pay?

Over the past 12 months, Mersana Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mersana Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Mersana Therapeutics?

The current dividend yield of Mersana Therapeutics is .

When does Mersana Therapeutics pay dividends?

Mersana Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mersana Therapeutics?

Mersana Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Mersana Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mersana Therapeutics located?

Mersana Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mersana Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mersana Therapeutics from 5/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/28/2024.

When did Mersana Therapeutics pay the last dividend?

The last dividend was paid out on 5/28/2024.

What was the dividend of Mersana Therapeutics in the year 2023?

In the year 2023, Mersana Therapeutics distributed 0 USD as dividends.

In which currency does Mersana Therapeutics pay out the dividend?

The dividends of Mersana Therapeutics are distributed in USD.